Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
Condition(s):Acne VulgarisLast Updated:March 3, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Acne VulgarisLast Updated:March 3, 2020Completed
Condition(s):AcneLast Updated:April 3, 2019Completed
Condition(s):Dermatitis HerpetiformisLast Updated:December 14, 2017Terminated
Condition(s):Acne VulgarisLast Updated:July 27, 2022Completed
Condition(s):Acne VulgarisLast Updated:February 27, 2015Completed
Condition(s):Acne VulgarisLast Updated:April 24, 2019Completed
Condition(s):Benign Mucous Membrane PemphigoidLast Updated:February 9, 2021Unknown status
Condition(s):Lichen Simples Chronicus and PrurigoLast Updated:June 5, 2013Unknown status
Condition(s):Acne VulgarisLast Updated:August 19, 2015Completed
Condition(s):Adult Immune Thrombocytopenia (ITP); DapsoneLast Updated:July 26, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.